AVP/SECTION HEAD, METABOLISM - GLOBAL CLINICAL DEVELOPMENT

Company: MERCK
Location: Boston
Posted on: November 6, 2024

Job Description:

Job Description
If you think you are the right match for the following opportunity, apply after reading the complete description.
The Associate Vice President (AVP)/ Metabolism Section Head in the Atherosclerosis & Metabolism Therapeutic Area within Global Clinical Development will focus on driving strategy, development, and life-cycle management activities for assets and products for the treatment of metabolic disorders, with emphasis on obesity and obesity-related metabolic disorders including Metabolic Dysfunction-Associated Steatohepatitis (MASH). The individual will be responsible for overseeing Product Development Team Leaders and Clinical Directors within their group to ensure successful execution of programs according to approved strategies and development plans, and to ensure optimal trial design and monitoring of studies, producing high-quality clinical documents and presentations. The position requires a solid understanding of the disease area, the functions and processes relevant to drug development, and project management principles applicable to the pharmaceutical industry. Primary Responsibilities:

• Leads late-stage development for multiple Metabolism projects, including pipeline candidates and licensed products.
• Supervises development of clinical documents including protocols, clinical study reports, and background documents for internal use or for submission to regulatory agencies.
• Interfaces with functional experts across the enterprise to ensure operational excellence in the late development of assets within the Metabolism Section of Global Clinical Development.
• May serve as a senior therapeutic area content expert within the company, providing input into research and business development priorities and prioritization of clinical assets.
• May serve as the senior liaison for relevant stakeholders in the external community (Scientific Leaders, Patient Community, Payers, Regulatory Agencies).
• Responsible for managing, coaching, and mentoring Clinical Directors and developing the future talent pool. Education:
  • M.D or M.D./Ph.D.
  • Board Certified in Endocrinology, Diabetes & Metabolism; Obesity Medicine; or Gastroenterology preferred. Required Experience and Skills:
    • Relevant industry experience bringing drugs and leading teams through various stages of clinical development, with emphasis on late-stage development.
    • Experience with planning and execution of strategies for product registration, commercialization and life-cycle management.
    • Strong leadership skills with a proven track record of hiring, mentoring, and retaining top talent.
    • Demonstrated ability to collaborate and network well within the organization; widely recognized within the organization as an expert in metabolic disorders and drug development.
    • Demonstrated ability to understand and manage, with appropriate support, the resources, time, and budgets for assigned projects; is business-savvy and results-oriented.
    • Proven ability to analyze, recommend, and communicate scientific information and influence cross-functional team initiatives.
    • Excellent written and oral communication skills.
    • Strong interpersonal skills and executive presence to successfully engage with internal senior leaders and the external scientific community. This is a US site-based role, which includes Rahway, NJ, Upper Gwynedd, PA and Boston, MA.
      #J-18808-Ljbffr

Keywords: MERCK, Leominster , AVP/SECTION HEAD, METABOLISM - GLOBAL CLINICAL DEVELOPMENT, Healthcare , Boston, Massachusetts